Inhibition of nitric oxide synthesis during severe shock but not after resuscitation increases hepatic injury and neutrophil accumulation in hemorrhaged rats

Shock

Volumn 8, Issue 6, 1997, Pages 415-421

  Harbrecht, Brian G ^a   Wu, Bin ^a   Watkins, Simon C ^b   Billiar, Timothy R ^a   Peitzman, Andrew B ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRHEUMATIC AGENT; ASPARTATE AMINOTRANSFERASE; ENZYME INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; ORNITHINE CARBAMOYLTRANSFERASE; PENICILLAMINE; PEROXIDASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLEEDING; BLOOD; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM; ENZYMOLOGY; HEMORRHAGIC SHOCK; INTESTINE; LIVER DISEASE; LUNG; MALE; METABOLISM; NEUTROPHIL; RAT; RESUSCITATION; SPRAGUE DAWLEY RAT; TIME;

ALANINE TRANSAMINASE; ANIMALS; ANTIRHEUMATIC AGENTS; ASPARTATE AMINOTRANSFERASES; ENDOTHELIUM; ENZYME INHIBITORS; HEMORRHAGE; INTESTINES; LIVER DISEASES; LUNG; MALE; NEUTROPHILS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; ORNITHINE CARBAMOYLTRANSFERASE; PENICILLAMINE; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; RESUSCITATION; SHOCK, HEMORRHAGIC; TIME FACTORS;

EID: 0031306612     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/00024382-199712000-00004     Document Type: Article

References (40)

1. Deitch EA: Multiple organ failure: Pathophysiology and potential future therapy. Ann Surg 216:117-134, 1992.
2. Blalock A: Shock: Further studies with particular reference to the effects of hemorrhage. Arch Surg 29:837-857, 1937.
3. Schoeniger LO, Reilly PM, Bulkley GB, Buchman TG: Heat-shock gene expression excludes hepatic acute-phase gene expression after resuscita tion from hemorrhagic shock. Surgery 112:355-363, 1992.
4. Rhodes RS, DePalma RG: Mitochondrial dysfunction of the liver and hypoglycemia in hemorrhagic shock. Surg Gynecol Obstet 150:347-352, 1980.
5. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB 7 6:3051-3064, 1992.
6. Thiemermann C, Szabó C, Mitchell JA, Vane JR: Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemor rhagic shock is mediated by nitric oxide. Proc Natl Acad Sci USA 90: 267-271, 1993.
7. Szabó C, Farago M, Horvath I, Lohinai Z, Kovach AGB: Hemorrhagic hypotension impairs endothelium-dependent relaxations in the renal artery of the cat. Circ Shock 36:238-241, 1992.
8. Wang P, Ba ZF, Chaudry IH: Endothelial cell dysfunction occurs very early following trauma-hemorrhage and persists despite fluid resuscita tion. Am J Physiol 265:H973-H979, 1993.
9. Symington PA, Ma X-L, Lefer AM: Protective actions of S-nitroso-N- acetylpenicillamine (SNAP) in a rat model of hemorrhagic shock. Methods Find Exp Clin Pharmacol 14:789-797, 1992.
10. Payne D, Kubes P: Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability. Am J Physiol 265:G189-G195, 1993.
11. Kurose I, Wolf R, Grisham MB, Granger DN: Modulation of ischemia/ reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res 74:376-382, 1994.
12. Christopher TA, Ma X-L, Lefer AM: Beneficial actions of S-nitroso-N- acetylpenicillamine, a nitric oxide donor, in murine traumatic shock. Shock 1:19-24, 1994.
13. Daughters K, Waxman K, Nguyen H: Increasing nitric oxide production improves survival in experimental hemorrhagic shock. Resuscitation 31: 141-144, 1996.
14. Harbrecht BG, Wu B, Watkins SC, Marshall HP Jr, Peitzman AB, Billiar TR: Inhibition of nitric oxide synthase during hemorrhagic shock increases hepatic injury. Shock 4:332-337, 1995.
15. Kelly E, Shah N, Morgan NN, Watkins SC, Peitzman AB, Billiar TR: Physiologic and molecular characterization of the role of nitric oxide in hemorrhagic shock: Evidence that type II nitric oxide synthase does not regulate vascular decompensation. Shock 7:157-163, 1997.
16. Bond RF, Johnson G III: Vascular adrenergic interactions during hemor rhagic shock. Fed Proc 44:281-289, 1989.
17. Harbrecht BG, Stadler J, Demetris AJ, Simmons RL, Billiar TR: Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. Am J Physiol 266:G1004-G1010, 1994.
18. Oshita M, Takeda H, Kamiyama Y, Ozawa K, Honjo I: A direct method for the estimation of ornithine carbamoyltransferase in serum. Clin Chem Acta 67:145-152, 1976.
19. Allan G, Bhattacherjee P, Brook CD, Read NG, Parke AJ: Myeloperoxi dase activity as a quantitative marker of polymorphonuclear leukocyte accumulation into an experimental myocardial infarct: The effect of ibu profen on infarct size and polymorphonuclear leukocyte accumulation. 7 Cardiovasc Pharmacol 7:1154-1160, 1985.
20. Lieberthal W, McGary AE, Sheils J, Valeri CR: Nitric oxide inhibition in rats improves blood pressure and renal function during hypovolemic shock. Am J Physiol 261:F868-F872, 1991.
21. G-methyl-L-arginine restores ar terial pressure in hemorrhaged rats. Circ Shock 40:47-52, 1993.
22. Zingarelli B, Squadrito F, Altavilla D, et al: Evidence for a role of nitric oxide in hypovolemic hemorrhagic shock. 7 Cardiovasc Pharmacol 19: 982-986, 1992.
23. Pryor WA, Squadrito GL: The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide. Am 7 Physiol 268:L699- L722, 1995.
24. Szabd C: The pathophysiological role of peroxynitrite in shock, inflam mation, and ischemia-reperfusion injury. Shock 6:79-88, 1996.
25. Jacob TD, Ochoa JB, Udekwu AO, et al: Nitric oxide production is inhibited in trauma patients. 7 Trauma 35:590-596, 1993.
26. Vedder NB, Winn RK, Rice CL, Chi EY. Arfors K-E, Harlan JM: A monoclonal antibody to the adherence-promoting leukocyte glycoprotein, CD 18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. 7 Clin Invest 81:939-944, 1988.
27. Jaeschke H, Farhood A, Smith CW: Neutrophils contribute to ischemia/ reperfusion injury in rat liver in vivo. FASEB 7 4:3355-3359, 1990.
28. Langdale LA, Flaherty LC, Liggitt HD, Harlan JM, Rice CL, Winn RK: Neutrophils contribute to hepatic ischemia-reperfusion injury by a CD18- independent mechanism. J Leukocyte Biol 53:511-517, 1993.
29. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S: Characteriza tion of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br 7 Pharmacol 101:746-752, 1990.
30. Southan GS, Szabó C, Thiemermann C: Isothioureas: Potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 114:510-516, 1995.
31. Hauptman JG, DeJong GK, Blasko KA, Chaudry IH: Measurement of hepatocellular function, cardiac output, effective blood volume, and oxy gen saturation in rats. Am J Physiol 257:R439-R444, 1989.
32. Vromen A, Szabó C, Southan GS, Salzman AL: Effect of S-isopropyl isothiourea, a potent inhibitor of nitric oxide synthase, in severe hemor rhagic shock. J Appl Physiol 81:707-715, 1996.
33. 2+ mobilization and ni tric oxide biosynthesis in cultured endothelial cells. Circ Res 75:659-668, 1994.
34. Myers PR, Zhong Q, Jones JJ, Tanner MA, Adams HR, Parker JL: Release of EDRF and NO in ex vivo perfused aorta: Inhibition by in vivo E. coli endotoxin. Am J Physiol 268:H953-H961, 1995.
35. Yao Y-M, Bahrami S, Leichtfried G, Redl H, Schlag G: Significance of NO in hemorrhage-induced hemodynamic alterations, organ injury, and mortality in rats. Am J Physiol 270:H1616-H1623, 1996.
36. ω-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 176:1175-1182, 1992.
37. Robertson FM, Offner PJ, Ciceri DP, Becker WK, Pruitt BA Jr: Detri mental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 129:149-156, 1994.
38. Harbrecht BG, Billiar TR, Stadler J, Demetris AJ, Ochoa J, Curran RD, Simmons RL: Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J Leukocyte Biol 52:390-394, 1992.
39. Szabö C, Southan GJ, Thiemermann C: Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91:12472-12476, 1994.
40. Thiemermann C, Ruetten H, Wu C-C, Vane JR: The multiple organ dysfunction syndrome caused by endotoxin in the rat: The attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 116:2845-2851, 1995.